NEO

NeoGenomics (NEO)

NeoGenomics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NEO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/30	20 : 30	Business Wire	NeoGenomics Reports First Quarter 2024 Results	NASDAQ:NEO	NeoGenomics Inc
2024/04/18	20 : 05	Business Wire	NeoGenomics Announces Senior Leadership Promotions	NASDAQ:NEO	NeoGenomics Inc
2024/04/09	20 : 00	Business Wire	NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024	NASDAQ:NEO	NeoGenomics Inc
2024/03/27	21 : 30	Business Wire	NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting	NASDAQ:NEO	NeoGenomics Inc
2024/03/20	20 : 00	Business Wire	NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report	NASDAQ:NEO	NeoGenomics Inc
2024/03/07	06 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/03/05	07 : 33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NEO	NeoGenomics Inc
2024/03/01	21 : 05	Business Wire	NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference	NASDAQ:NEO	NeoGenomics Inc
2024/02/28	06 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/28	06 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/28	06 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/28	06 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/27	06 : 15	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:NEO	NeoGenomics Inc
2024/02/21	06 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/21	06 : 23	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:NEO	NeoGenomics Inc
2024/02/21	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NEO	NeoGenomics Inc
2024/02/21	06 : 05	Business Wire	NeoGenomics Reports Fourth Quarter and Full Year 2023 Results	NASDAQ:NEO	NeoGenomics Inc
2024/02/20	19 : 37	IH Market News	Market Cautiousness Ahead of Retail Giants’ Earnings; Oil Prices Dip	NASDAQ:NEO	NeoGenomics Inc
2024/02/16	06 : 26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/15	00 : 04	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:NEO	NeoGenomics Inc
2024/02/10	05 : 17	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:NEO	NeoGenomics Inc
2024/02/01	21 : 05	Business Wire	NeoGenomics Signs Working with Cancer Pledge in Support of Employees	NASDAQ:NEO	NeoGenomics Inc
2024/01/30	21 : 05	Business Wire	NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024	NASDAQ:NEO	NeoGenomics Inc
2024/01/04	07 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/01/02	21 : 05	Business Wire	NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:NEO	NeoGenomics Inc
2023/12/12	09 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2023/12/06	06 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2023/11/21	06 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2023/11/18	06 : 25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NEO	NeoGenomics Inc
2023/11/07	06 : 29	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NEO	NeoGenomics Inc